Skip to main content
Erschienen in: Journal of General Internal Medicine 8/2020

24.03.2020 | Letter to the Editor

Prescribers and Naloxone Pharmacy Claims

verfasst von: Rosanna Smart, PhD, Caroline K. Geiger, BA, Christopher M. Jones, PharmD, MPH, Bradley D. Stein, PhD

Erschienen in: Journal of General Internal Medicine | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Excerpt

We appreciate the response from Truong, Patil, and Rich to our study regarding retail pharmacy naloxone prescriptions1 and thank them for highlighting the importance of patient and caregiver education for individuals receiving naloxone. While naloxone is generally considered a safe medication, like almost all medications, there are risks of unintended adverse consequences if not used as intended. It is essential that prescribers educate patients and caregivers regarding the circumstances when naloxone should be administered, and the procedures for administering it, when writing a naloxone prescription. In addition, since nearly all states have laws or policies that allow individuals to obtain naloxone from a pharmacist without a prescription from a physician, pharmacists also play a critical role in counseling patients and caregivers regarding the circumstances when naloxone should be administered and proper procedures for administration.2
Literatur
1.
Zurück zum Zitat Smart R, Geiger CK, Jones CM, Stein BD. An Observational Study of Retail Pharmacy Naloxone Prescriptions: Differences Across Provider Specialties and Patient Populations. J Gen Intern Med. 2019. Smart R, Geiger CK, Jones CM, Stein BD. An Observational Study of Retail Pharmacy Naloxone Prescriptions: Differences Across Provider Specialties and Patient Populations. J Gen Intern Med. 2019.
2.
Zurück zum Zitat Thakur T, Frey M, Chewning B. Pharmacist roles, training, and perceived barriers in naloxone dispensing: A systematic review. J Am Pharm Assoc (2003). 2020;60(1):178–94. Thakur T, Frey M, Chewning B. Pharmacist roles, training, and perceived barriers in naloxone dispensing: A systematic review. J Am Pharm Assoc (2003). 2020;60(1):178–94.
3.
Zurück zum Zitat Zaller ND, Yokell MA, Green TC, Gaggin J, Case P. The feasibility of pharmacy-based naloxone distribution interventions: a qualitative study with injection drug users and pharmacy staff in Rhode Island. Subst Use Misuse. 2013;48(8):590–9.CrossRef Zaller ND, Yokell MA, Green TC, Gaggin J, Case P. The feasibility of pharmacy-based naloxone distribution interventions: a qualitative study with injection drug users and pharmacy staff in Rhode Island. Subst Use Misuse. 2013;48(8):590–9.CrossRef
Metadaten
Titel
Prescribers and Naloxone Pharmacy Claims
verfasst von
Rosanna Smart, PhD
Caroline K. Geiger, BA
Christopher M. Jones, PharmD, MPH
Bradley D. Stein, PhD
Publikationsdatum
24.03.2020
Verlag
Springer International Publishing
Erschienen in
Journal of General Internal Medicine / Ausgabe 8/2020
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-05791-5

Weitere Artikel der Ausgabe 8/2020

Journal of General Internal Medicine 8/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.